Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 22 - Number 13



Historical Hallmarks of Anticoagulation and Antiplatelet Agents

, 22(13): 1857 - 1861

Gregory Tsoucalas, Jacques Chevallier, Marianna Karamanou, Theodoros Papaioannou, Markos Sgantzos and George Androutsos


DOI: 10.2174/1381612822666160111124615





Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations

, 22(13): 1888 - 1895

Nikolaos A. Magkoutis, Sabi Fradi, Alexandre Azmoun, Ramsi Ramadan, Sami Ben Ouanes, Manolis Vavuranakis, Dimitrios A. Vrachatis, Theodore G. Papaioannou, Dimitrios Tousoulis and Saïd Ghostine


DOI: 10.2174/1381612822666160222115936


Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations

, 22(13): 1896 - 1903

Manolis Vavuranakis, Angelos–Michail Kolokathis, Dimitrios A. Vrachatis, Konstantinos Kalogeras, Nikolaos A. Magkoutis, Sabi Fradi, Saïd Ghostine, Marianna Karamanou and Dimitrios Tousoulis


DOI: 10.2174/1381612822666151208123050










Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog